[KROS] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
25-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 11.30%
YoY- -288.08%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 0 100 0 0 2,500 2,500 2,500 -
PBT -20,335 -15,622 -15,835 -10,676 -12,036 -10,757 -12,064 41.58%
Tax -38 -79 50 82 -156 1 -172 -63.42%
NP -20,297 -15,622 -15,885 -10,676 -12,036 -10,757 -11,892 42.77%
Tax Rate - - - - - - - -
Total Cost 20,297 15,722 15,885 10,676 14,536 13,257 14,392 25.73%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 0.00 -15,622.00 0.00 0.00 -481.44 -430.28 -475.68 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.87 -0.67 -0.68 -0.49 -0.60 -0.61 -0.65 21.43%
EPS Diluted -0.87 -0.67 -0.68 -0.49 -0.60 -0.61 -0.65 21.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.